Transoperative pain management: A framework - DVM
News Center
DVM Featuring Information from:


Transoperative pain management: A framework
To make your pain control measures top-notch, construct a scaffold of appropriate pain medications


9. Benedetti F, Amanzio M, Vighetti, et al. The biochemical and neuroendocrine bases of the hyperalgesic nocebo effect. J Neruosci 2006;26(46):12014-12022.

10. Martenson ME, Cetas JS, Heinricher MM. A possible neural basis for stress-induced hyperalgesia. Pain 2009;142(3):236-244.

11. Wang XM, Wu TX, Hamza M, et al. Rofecoxib modulates multiple gene expression pathways in a clinical model of acute inflammatory pain. Pain 2007;128(1-2):136-147.

12. Schottelius AJ, Giesen C, Asadullah K, et al. An aspirin-triggered lipoxin A4 stable analog displays a unique topical anti-inflammatory profile. J Immunol 2002;169(12):7063-7070.

13. Lascelles BD, Cripps PJ, Jones A, et al. Efficacy and kinetics of carprofen, administered preoperatively or postoperatively, for the prevention of pain in dogs undergoing ovariohysterectomy. Vet Surg 1998;27(6):568-582.

14. Barkin RL, Iusco M, Barkin SJ. Opioids used in primary care for the management of pain: a pharmacologic, pharmacotherapeutic, and pharmacodynamics overview. In: Boswell MV, Cole BE, eds. Weiner's pain management: a practical guide for clinicians. 7th ed. Boca Raton, Fla: Taylor & Francis, 2006;791.

15. Scotto di Fazano C, Vergne P, Grilo RM, et al. Preventive therapy for nausea and vomiting in patients on opioid therapy for non-malignant pain in rheumatology. Therapie 2002;57(5):446-449. [In French.]

16. Taylor PM, Robertson SA, Dixon MJ, et al. Morphine, pethidine and buprenorphine disposition in the cat. J Vet Pharmacol Ther 2001;24:391-398.

17. Niedfeldt RL, Robertson SA. Postanesthetic hyperthermia in cats: a retrospective comparison between hydromorphone and buprenorphine. Vet Anaesth Analg 2006;33(6):381-389.

18. Egger CM, Glerum LE, Allen SW, et al. Plasma fentanyl concentrations in awake cats and cats undergoing anesthesia and ovariohysterectomy using transdermal administration. Vet Aneasth Analg 2003;30(4):229-236.

19. Kyles AE, Papich M, Hardie EM. Disposition of trnasdermally administered fentanyl in dogs. Am J Vet Res 1996;57(5):715-719.

20. Lascelles BD, Robertson SA, Taylor PM, et al. Proceedings of the 27th Annual Meeting of the American College of Veterinary Anesthesiologists, Orlando, Florida, October 2002.

21. Robertson SA, Taylor PM, Sear JW. Systemic uptake of buprenorphine by cats after oral mucosal administration. Vet Rec 2003;152(22):675-678.

22. Grimm KA, Tranquilli WJ, Thurmon JC, et al. Duration of nonresponse to noxious stimulation after intramuscular administration of butorphanol, medetomidine, or a butorphanol-medetomidine combination during isoflurane administration in dogs. Am J Vet Res 2000;61(1):42-47.

23. Sawyer DC, Rech RH, Durham RA, et al. Dose response to butorphanol administered subcutaneously to increase visceral nociceptive threshold in dogs. Am J Vet Res 1991;52(11):1826-1830.

24. Carr DB. Opioid side effects, In: IASP Pain Clinical Updates, April 2007 XV:2.

25. Johnson SM, Saint John BE, Dine AP. Local anesthetics as antimicrobial agents: a review. Surg Infect 2008;9(2):205-213.


Source: DVM360 MAGAZINE,
Click here